Search

STAAR Surgical Co

Closed

SectorHealthcare

26.14 3.36

Overview

Share price change

24h

Current

Min

24.7

Max

26.2

Key metrics

By Trading Economics

Income

5.2M

5.2M

Sales

36M

94M

EPS

-0.23

Profit margin

5.567

Employees

921

EBITDA

19M

10M

Recommendations

By TipRanks

Recommendations

Neutral

12 Months Forecast

+18.44% upside

Dividends

By Acuity

Next Earnings

3 lis 2026

Market Stats

By TradingEconomics

Market Cap

-135M

1.3B

Previous open

22.78

Previous close

26.14

News Sentiment

By Acuity

23%

77%

79 / 340 Ranking in Healthcare

STAAR Surgical Co Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

14 sie 2026, 23:46 UTC

STAAR Surgical Co. shares declined after-market, reflecting broader market sentiment amid an unexpected drop in U.S. retail sales for July.

13 sie 2026, 20:02 UTC

Social Media
News

STAAR Surgical shares are lower after UBS cut its price target to $19.00, despite reporting strong second-quarter sales of $93.5 million.

12 sie 2026, 23:56 UTC

Social Media
News

STAAR Surgical shares are lower in after-market hours following an EPS miss, despite reporting second-quarter net sales of $93.5 million, a 111% increase.

11 sie 2026, 20:01 UTC

News

STAAR Surgical Co shares are lower today, reflecting broader market declines amid rising oil prices and inflation concerns ahead of U.S. inflation reports.

10 sie 2026, 20:02 UTC

Social Media
News

Broadwood has acquired over 1 million additional shares of STAAR Surgical, reflecting its long-term strategy, as the stock trades higher since Friday's close.

7 sie 2026, 22:56 UTC

Shares of STAAR Surgical Co. are trading higher in after-market hours, continuing a positive trend amid a supportive market backdrop following a decline in the unemployment rate.

6 sie 2026, 20:03 UTC

STAAR Surgical Co. shares are higher today, reflecting gains since Wednesday's close, though the stock remains below its 20-day moving average.

5 sie 2026, 20:02 UTC

STAAR Surgical shares are lower today, continuing a decline since Tuesday's close amid broader market volatility and external factors not directly impacting the company.

4 sie 2026, 19:51 UTC

STAAR Surgical Co shares are lower as Health Care Supplies sub-sector performance weighs on the stock. No specific news was identified for the decline.

3 sie 2026, 20:03 UTC

No specific news for STAAR Surgical as shares trade near unchanged. The broader market sees gains amid strong buying interest in technology stocks.

31 lip 2026, 19:52 UTC

STAAR Surgical Co shares are lower amid weakness in the Health Care Supplies sub-sector. The stock has seen modest declines since Thursday's close.

30 lip 2026, 19:29 UTC

STAAR Surgical Co. shares are lower today, reflecting a decline since Wednesday amid broader market volatility and rising Treasury yields.

29 lip 2026, 22:11 UTC

STAAR Surgical Co shares are lower in after-market hours amid significant declines in the Health Care Supplies sub-sector, with no specific news identified.

28 lip 2026, 18:56 UTC

News

STAAR Surgical Co shares declined after UBS initiated coverage with a Sell rating and set a price target of $20.00, closing at $22.95.

27 lip 2026, 19:07 UTC

STAAR Surgical Co. shares are trading lower, continuing a recent downward trend amid broader market sentiment affected by declining crude oil prices.

22 lip 2026, 18:11 UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

21 lip 2026, 16:56 UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

20 lip 2026, 20:01 UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Peer Comparison

Price change

STAAR Surgical Co Forecast

Price Target

By TipRanks

18.44% upside

12 Months Forecast

Average 30 USD  18.44%

High 40 USD

Low 20 USD

Based on 7 Wall Street analysts offering 12 month price targets forSTAAR Surgical Co - Dist in the last 3 months.

Rating Consensus

By TipRanks

Neutral

7 ratings

2

Buy

4

Hold

1

Sell

Sentiment

By Acuity

79 / 340 Ranking in Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat